Bath PUVA and Psoriasis: Is a Milder Treatment a Worse Treatment?

Abstract

Background/Aim: The guidelines of the British Photodermatology Group for topical treatment with psoralen and ultraviolet light (PUVA) recommend starting UVA doses between 0.2 and 0.5 J/cm², according to the phototype. Our purpose was to evaluate the therapeutic efficacy and tolerability of bath PUVA, with 8-methoxypsoralen (8-MOP), by using lower UVA doses, regardless of phototype. Methods: We compared 2 groups of patients (group 1: n = 10, group 2: n = 20) with chronic plaque-type psoriasis. Group 1 was treated with the usual starting dose and dose progression; group 2 was treated by using a lower first dose, a slower dose progression and reaching a lower maximum dose. The Psoriasis Area and Severity Index (PASI) score was assessed at the initial stages, and every month until the end of the treatment. Results: In group 1, the median baseline PASI score decreased from 15.2 to 4.5 (p < 0.005, Student’s paired t test), while in group 2, it fell from 13.7 to 4.1 (p < 0.005). No statistical difference between the groups is detectable. Severe phototoxic reactions were observed only in 2 patients of group 1. Side effects were not observed in group 2. Conclusions: Our data indicate that an aggressive bath PUVA treatment is not substantially more effective in clearing chronic plaque-type psoriasis than a milder therapeutic approach.

Effectiveness and Safety of Topical Phototherapy in the Treatment of Dermatological Diseases

“…Literature reports encourage results obtained with bath-PUVA in the treatment of several inflammatory [38][39][40][41][42][43][44][45][46][47] and lymphoproliferative skin diseases [48][49][50][51][52]. Figures 1-4 report same examples of results obtained with bath-PUVA at our center.…”

Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy

“…Zhan et al targeting drugs are confronted with problems such as too large dose because of well distribution inside the whole body and potential severe phototoxicity all over the body in clinics; 13,14 hence, specific targeting and controlled release of photosensitizers are urgent demands in clinics. Although researches on the delivery system of photosensitizers have flourished in recent years, low enriching efficiency of photosensitizers still severely hamper the therapeutic effect of PDT.…”

Conceptos actuales de medicina basada en la evidencia sobre el uso de fototerapia en psoriasis

“…La fototerapia con UVB ejerce sus efectos por medio de varios mecanismos. Su blanco principal es el ADN nuclear el cual absorbe los rayos de luz, generando dímeros de pirimidinas y otros fotoproductos que inhiben la síntesis de ADN; esto hace que el ciclo celular se detenga y se disminuya la proliferación de linfocitos y queratinocitos 10 . Además, aumenta la expresión de p53, un gen supresor de tumores que regula el ciclo celular, causa apoptosis de linfocitos, disminuye la concentración de células de Langerhans y afecta la producción de citocinas por parte de las células inflamatorias 1,11 .…”

“…Kleinpenning, et al, llevaron a cabo un estudio doble ciego de asignación aleatoria en el 2009, en el cual se demostró que los esquemas con dosis altas eran más costo-efectivos y requerían menos sesiones de tratamiento que los de dosis bajas 24 . Algunos recomiendan incrementos de 10 a 20 % de la DEM en cada sesión; otros usan incrementos altos (15 a 20 %) al inicio del tratamiento y, luego, incrementos de 10 % en sesiones posteriores 7,10 . Algunos emplean aumentos de 30 a 40 % por semana 30 , pero los de 5 a 10 % han sido efectivos 25,27 .…”